Content provided in partnership with

Biotech People

* Pilot Therapeutics of Winston-Salem has made three new management appointments. Floyd H. Chilton, Ph.D., the company's founder and chief scientific officer, has assumed the additional role of chief executive officer. He was formerly the director of molecular medicine, professor of internal medicine and physiology/pharmacology at Wake Forest University. Retaining his position as chief operating officer, Kenneth M. Tramposch, Ph.D., advances from executive vice president to president of Pilot. Tramposch was most recently with a Bristol-Myers Squibb division in Buffalo, N.Y. Also, board member Russell E. Armistead has been appointed chief financial officer. He formerly held top administrative posts at Wake Forest University. Sara Brooks Strassle, president and CEO of Pilot since 1999, retains her position as a member of the board of directors.

Most Popular Articles in Technology: An overview of continuous data protection; Why all those current ratings?; Many countries now have a mobile penetration rate above 100%, report says; The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...; MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...; More »

* Paradigm Genetics Inc. (Nasdaq: PDGM) of Research Triangle Park has appointed Ken Hunt to the newly created position of vice president of marketing. Hunt joins Paradigm from Monsanto of St. Louis, Mo., bringing with him 8 years of strategic business development and marketing experience.

* PPD Inc. (Nasdaq: PPDI) of Wilmington has added Catherine M. Klema of SG Cowen Securities of New York, N.Y., to its board of directors.

* Donald Kelemen of Ensolve Biosystems Inc. of Raleigh has received an Industrial Innovation Award from the American Chemical Society of Washington, D.C., for his development of the company's PetroLiminator [TM]. The filtering system collects ship bilgewater and uses oil-devouring bacteria to eat up the unseparated, emulsified oil.

* A.M. Pappas & Associates of Research Triangle Park has appointed Dr. Cedric Pearce to the position of vice president of discovery technologies. Pearce was recently with MYCOsearch Inc. of Durham, a subsidiary of OSI Pharmaceuticals of Uniondale, N.Y.

Technology Industry

Biotech People

BT Catalyst, Jan, 2001

Find Research Guides for:

Find Featured Titles for: Sports

Most Popular Articles in Technology

Most Popular Publications in Technology